Revista de Neurooncología y Neurociencia Acceso abierto

Abstracto

Nucleo-liposomes as neurotracer for SPECT and anti-cancer drug delivery agent

Swastika Mishra

The Blood-Brain Barrier (BBB) is a major obstacle for drug delivery to the brain. Nucleolipid based liposomes are promising drug delivery systems allowing in vivo trackingusing molecular imaging techniques and have proved promising theranostics agents especially for tumors. However, an efficient liposomal preparations for theranostic of neuro-onco, neuro-infection and neurodegenerative diseases needs further research. Nucleolipidic liposomes (NL-Nps) are of great interest because of the site-recognition (nucleoside), lipophilicity (long alkyl chain) and better membrane translocation by interaction of fatty acid with the lipid bilayer. Thus, we have evaluated uridine derived nucleolipidic liposomes for encapsulation efficiencies of MTX (Methotrexate) anti-cancer and sulfanilamide anti-infection drug and in vivo tracking by radiolabeling with^99mTc.

Materials&Method:(NL-Nps)were prepared using NL-DTPA (synthesized), heatedto50°C when mixed with organic solvent and added to a queous phase containing the surfactant Tween-80 andtheco-surfactant soyalecithin.NL-Nps were encapsulated with MTX and sulfanilamide were similarly prepared by adding drugs (0.1 to 1.5%) to the formulation. NL-Nps were evaluated for release kinetics and brain targeting in BMG-1 (brain glioma) and neuronal cell line in murine model.

Results: Multi-step synthesis leads to the final compound (NL-DTPA) and its liposomal preparation (size 113 to 130 nm, zeta potential -14 to -28 mV) with EEs of 64% was achieved. Liposomes showed sustained drug release for 2-5 days negligible hemolytic activity, no cytotoxicityinHEKcells.Radio labeling efficiency  of 98% was  achieve dusing^99mTcconferring prolonge dsystemic circulation and renal routeex cretion.The biodistribution showed 1.8% ID/gm to 2.3% ID/gm for intact versus disrupted BBB in mice models. (NL-Nps) also in BMG tumor mice depicted higher tumor uptake(2.3T/M).

Conclusion:

Nucleolipid functionalized liposomes as candidates to be used as biocompatible nanocarrier systems with high systemic retention and anti-tumor effects. Future work will concentrate on targeting of liposomes in brain tumor model using stereotaxis.